Dr Kevin Gawain Spaeth, | |
333 Smith Ave N, Saint Paul, MN 55102-2344 | |
(651) 735-0501 | |
(651) 735-1870 |
Full Name | Dr Kevin Gawain Spaeth |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 21 Years |
Location | 333 Smith Ave N, Saint Paul, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124140165 | NPI | - | NPPES |
210097000 | Medicaid | MN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 48054 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
Healtheast Woodwinds Hospital | Woodbury, MN | Hospital |
Allina United Hospital | Saint paul, MN | Hospital |
Healtheast St John's Hospital | Maplewood, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Metropolitan Anesthesia Network Llp | 5698689123 | 647 |
News Archive
Asthma is a serious disease that when left undertreated, can be deadly. In fact, asthma accounts for 4,000 deaths annually in the United States alone. And according to a new International Consensus (ICON) on Pediatric Asthma, an alarming 50 percent of children worldwide have uncontrolled symptoms, despite today's available treatments.
Can whole genome sequencing illustrate changes in drug susceptibility of gonorrhoea to antimicrobials used for treatment and so help to define more effective treatment regimens? The first study of this kind within an international surveillance programme for sexually transmitted infections shows distribution of drug-resistant gonorrhoea strains across Europe.
The U.S. Food and Drug Administration released a report today updating the clinical and scientific information for silicone gel-filled breast implants, including preliminary safety data from studies conducted by the manufacturers as a condition of their November 2006 approval.
Dutch researcher Joost Wiersinga from AMC Medical Centre in Amsterdam has unravelled a genetic defence mechanism against the lethal bacteria Burkholderia pseudomallei. The research is the next step towards a vaccine against this bacterium suitable for bioweapons.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that its subsidiary company Simcere Dongyuan Pharmaceutical Co., Ltd. has recently received SFDA new drug certification and registration approval to manufacture and market Palonosetron material and injections in China.
› Verified 2 days ago
Entity Name | Metropolitan Anesthesia Network Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558314427 PECOS PAC ID: 5698689123 Enrollment ID: O20031118000579 |
News Archive
Asthma is a serious disease that when left undertreated, can be deadly. In fact, asthma accounts for 4,000 deaths annually in the United States alone. And according to a new International Consensus (ICON) on Pediatric Asthma, an alarming 50 percent of children worldwide have uncontrolled symptoms, despite today's available treatments.
Can whole genome sequencing illustrate changes in drug susceptibility of gonorrhoea to antimicrobials used for treatment and so help to define more effective treatment regimens? The first study of this kind within an international surveillance programme for sexually transmitted infections shows distribution of drug-resistant gonorrhoea strains across Europe.
The U.S. Food and Drug Administration released a report today updating the clinical and scientific information for silicone gel-filled breast implants, including preliminary safety data from studies conducted by the manufacturers as a condition of their November 2006 approval.
Dutch researcher Joost Wiersinga from AMC Medical Centre in Amsterdam has unravelled a genetic defence mechanism against the lethal bacteria Burkholderia pseudomallei. The research is the next step towards a vaccine against this bacterium suitable for bioweapons.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that its subsidiary company Simcere Dongyuan Pharmaceutical Co., Ltd. has recently received SFDA new drug certification and registration approval to manufacture and market Palonosetron material and injections in China.
› Verified 2 days ago
Entity Name | Allina Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Asthma is a serious disease that when left undertreated, can be deadly. In fact, asthma accounts for 4,000 deaths annually in the United States alone. And according to a new International Consensus (ICON) on Pediatric Asthma, an alarming 50 percent of children worldwide have uncontrolled symptoms, despite today's available treatments.
Can whole genome sequencing illustrate changes in drug susceptibility of gonorrhoea to antimicrobials used for treatment and so help to define more effective treatment regimens? The first study of this kind within an international surveillance programme for sexually transmitted infections shows distribution of drug-resistant gonorrhoea strains across Europe.
The U.S. Food and Drug Administration released a report today updating the clinical and scientific information for silicone gel-filled breast implants, including preliminary safety data from studies conducted by the manufacturers as a condition of their November 2006 approval.
Dutch researcher Joost Wiersinga from AMC Medical Centre in Amsterdam has unravelled a genetic defence mechanism against the lethal bacteria Burkholderia pseudomallei. The research is the next step towards a vaccine against this bacterium suitable for bioweapons.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that its subsidiary company Simcere Dongyuan Pharmaceutical Co., Ltd. has recently received SFDA new drug certification and registration approval to manufacture and market Palonosetron material and injections in China.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kevin Gawain Spaeth, 8681 Eagle Point Blvd, Lake Elmo, MN 55042-8628 Ph: (651) 251-8021 | Dr Kevin Gawain Spaeth, 333 Smith Ave N, Saint Paul, MN 55102-2344 Ph: (651) 735-0501 |
News Archive
Asthma is a serious disease that when left undertreated, can be deadly. In fact, asthma accounts for 4,000 deaths annually in the United States alone. And according to a new International Consensus (ICON) on Pediatric Asthma, an alarming 50 percent of children worldwide have uncontrolled symptoms, despite today's available treatments.
Can whole genome sequencing illustrate changes in drug susceptibility of gonorrhoea to antimicrobials used for treatment and so help to define more effective treatment regimens? The first study of this kind within an international surveillance programme for sexually transmitted infections shows distribution of drug-resistant gonorrhoea strains across Europe.
The U.S. Food and Drug Administration released a report today updating the clinical and scientific information for silicone gel-filled breast implants, including preliminary safety data from studies conducted by the manufacturers as a condition of their November 2006 approval.
Dutch researcher Joost Wiersinga from AMC Medical Centre in Amsterdam has unravelled a genetic defence mechanism against the lethal bacteria Burkholderia pseudomallei. The research is the next step towards a vaccine against this bacterium suitable for bioweapons.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that its subsidiary company Simcere Dongyuan Pharmaceutical Co., Ltd. has recently received SFDA new drug certification and registration approval to manufacture and market Palonosetron material and injections in China.
› Verified 2 days ago
Nancy K Thorvilson, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 640 Jackson St, Saint Paul, MN 55101 Phone: 651-254-3456 Fax: 651-254-5560 | |
Thomas Laberge, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 640 Jackson St, Saint Paul, MN 55101 Phone: 651-254-3456 Fax: 651-254-5560 | |
Dr. Mark T Destache, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 333 Smith Ave N, Saint Paul, MN 55102 Phone: 651-735-0501 Fax: 651-735-1870 | |
Robert Gorman, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 640 Jackson St, Saint Paul, MN 55101 Phone: 651-254-3456 Fax: 651-254-5560 | |
Dr. Reid A Martinson, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 333 Smith Ave N, Saint Paul, MN 55102 Phone: 651-735-0501 Fax: 651-735-1870 | |
Deanna Siliciano, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 640 Jackson St, Saint Paul, MN 55101 Phone: 651-254-3456 Fax: 651-254-5560 | |
Sena Kihtir, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 255 Smith Ave N Ste 100, Saint Paul, MN 55102 Phone: 651-241-7246 |